Detection method for evaluating curative effect to treat angina pectoris by grisounites series drug treatment
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 上海中优医药高科技股份有限公司
- Publication Date
- 2009-01-21
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for evaluating the curative effect of nitroglycerin drugs, which evaluates the effectiveness of nitroglycerin drugs for treating angina pectoris by detecting and analyzing whether the individual mitochondrial acetaldehyde dehydrogenase gene ALDH2 has Glu504Lys variation, which belongs to drug detection technology field. Background technique
[0002] Angina pectoris is a clinical syndrome caused by coronary insufficiency, myocardial acute, temporary ischemia and hypoxia.
[0003] Nitroglycerin (Glyceryl trinitrate, GTN) has been a classic drug for treating angina pectoris for more than 130 years. Sublingual administration of nitroglycerin has a quick effect (the drug directly enters the blood, and the symptoms are generally relieved within 5 to 10 minutes). And it can avoid the first-pass effect of the liver (that is, the liver degrades most of the drugs absorbed through the gastrointestinal tract), which is the standa...